NCT04063800 (PREBOP) is a clinical trial in Prostatic Adenocarcinoma, sponsored by University Hospital, Brest.

Who is sponsoring NCT04063800?

NCT04063800 is sponsored by University Hospital, Brest.

What condition does NCT04063800 study?

NCT04063800 studies Prostatic Adenocarcinoma.

Is NCT04063800 still recruiting?

NCT04063800 is currently completed. Last updated 12 September 2019.

Last reviewed 2019-09-12 · How we verify

NCT04063800: PREBOP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-therapeutic MRI

Completed Last updated 12 September 2019

What this trial tests

trial in Prostatic Adenocarcinoma in 195 participants. Completed in 28 August 2018.

Timeline

26 June 2018

Primary endpoint
28 August 2018

28 August 2018

Quick facts

Lead sponsor	University Hospital, Brest
Status	Completed
Study type	OBSERVATIONAL
Enrollment	195
Start date	26 June 2018
Primary completion	28 August 2018
Estimated completion	28 August 2018
Sites	2 locations across France

Conditions studied

Prostatic Adenocarcinoma — all drugs for Prostatic Adenocarcinoma →

Sponsor

University Hospital, Brest

Who can join

18 and older, male only, with Prostatic Adenocarcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With 50% of post-operative biochemical failure, efficient predictive models are needed to guide post-operative management. Radiomic features are quantitative features extracted from medical imaging, supposed to be correlated with tumor heterogeneity. We aim to build and test three predictive models (clinical, radiomic and combined models).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04063800 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 12 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04063800.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing